Castelli M, Magni A, Bonollo G, Pavoni S, Frigerio F, Oliveira A
Protein Sci. 2023; 33(3):e4880.
PMID: 38145386
PMC: 10895457.
DOI: 10.1002/pro.4880.
Sager R, Backe S, Neckers L, Woodford M, Mollapour M
Methods Mol Biol. 2023; 2693:125-139.
PMID: 37540432
PMC: 10518168.
DOI: 10.1007/978-1-0716-3342-7_11.
Stachowski T, Nithianantham S, Vanarotti M, Lopez K, Fischer M
Protein Sci. 2023; 32(5):e4629.
PMID: 36938943
PMC: 10108437.
DOI: 10.1002/pro.4629.
Meka P, Amatya E, Kaur S, Banerjee M, Zuo A, Dobrowsky R
Bioorg Med Chem. 2022; 70:116940.
PMID: 35905686
PMC: 11664489.
DOI: 10.1016/j.bmc.2022.116940.
Morales-Guadarrama G, Garcia-Becerra R, Mendez-Perez E, Garcia-Quiroz J, Avila E, Diaz L
Cells. 2021; 10(7).
PMID: 34359928
PMC: 8304745.
DOI: 10.3390/cells10071758.
AUY922 induces retinal toxicity through attenuating TRPM1.
Shen C, Hsieh C, Jiang K, Lin C, Chiang N, Li T
J Biomed Sci. 2021; 28(1):55.
PMID: 34301262
PMC: 8306347.
DOI: 10.1186/s12929-021-00751-5.
The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with -Hsp90 Inhibition.
Mishra S, Liu W, Beebe K, Banerjee M, Kent C, Munthali V
J Med Chem. 2021; 64(3):1545-1557.
PMID: 33428418
PMC: 8996186.
DOI: 10.1021/acs.jmedchem.0c01700.
Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90-Client Interactions.
Paladino A, Woodford M, Backe S, Sager R, Kancherla P, Daneshvar M
Chemistry. 2020; 26(43):9459-9465.
PMID: 32167602
PMC: 7415569.
DOI: 10.1002/chem.202000615.
Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression.
Allain E, Rouleau M, Levesque E, Guillemette C
Br J Cancer. 2020; 122(9):1277-1287.
PMID: 32047295
PMC: 7188667.
DOI: 10.1038/s41416-019-0722-0.
Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity.
Zhang Z, Banerjee M, Davis R, Blagg B
Bioorg Med Chem Lett. 2019; 29(22):126676.
PMID: 31591016
PMC: 8483072.
DOI: 10.1016/j.bmcl.2019.126676.
Evaluation of [C]NMS-E973 as a PET tracer for visualisation of HSP90.
Vermeulen K, Naus E, Ahamed M, Attili B, Siemons M, Luyten K
Theranostics. 2019; 9(2):554-572.
PMID: 30809293
PMC: 6376183.
DOI: 10.7150/thno.27213.
The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant Melanoma.
Hsieh C, Shen C
Curr Treat Options Oncol. 2019; 20(3):22.
PMID: 30778775
DOI: 10.1007/s11864-019-0622-9.
Synthesis and Structure-Activity Relationships of Inhibitors That Target the C-Terminal MEEVD on Heat Shock Protein 90.
Rahimi M, Buckton L, Zaiter S, Kho J, Chan V, Guo A
ACS Med Chem Lett. 2018; 9(2):73-77.
PMID: 30555625
PMC: 6291811.
DOI: 10.1021/acsmedchemlett.7b00310.
Synthesis and evaluation of a ring-constrained Hsp90 C-terminal inhibitor that exhibits neuroprotective activity.
Zhang Z, You Z, Dobrowsky R, Blagg B
Bioorg Med Chem Lett. 2018; 28(16):2701-2704.
PMID: 29759728
PMC: 6119633.
DOI: 10.1016/j.bmcl.2018.03.071.
Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor.
Khandelwal A, Kent C, Balch M, Peng S, Mishra S, Deng J
Nat Commun. 2018; 9(1):425.
PMID: 29382832
PMC: 5789826.
DOI: 10.1038/s41467-017-02013-1.
Detecting Posttranslational Modifications of Hsp90.
Sager R, Woodford M, Neckers L, Mollapour M
Methods Mol Biol. 2017; 1709:209-219.
PMID: 29177662
PMC: 6376113.
DOI: 10.1007/978-1-4939-7477-1_16.
Development of noviomimetics that modulate molecular chaperones and manifest neuroprotective effects.
Forsberg L, Anyika M, You Z, Emery S, McMullen M, Dobrowsky R
Eur J Med Chem. 2017; 143:1428-1435.
PMID: 29137866
PMC: 5736410.
DOI: 10.1016/j.ejmech.2017.10.038.
Involvement of cell surface 90 kDa heat shock protein (HSP90) in pattern recognition by human monocyte-derived macrophages.
Bzowska M, Nogiec A, Bania K, Zygmunt M, Zarebski M, Dobrucki J
J Leukoc Biol. 2017; 102(3):763-774.
PMID: 28550115
PMC: 5557637.
DOI: 10.1189/jlb.2MA0117-019R.
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics.
Li Q, Hao J, Zhang Z, Krane L, Hammerich K, Sanford T
Sci Rep. 2017; 7(1):201.
PMID: 28298630
PMC: 5427839.
DOI: 10.1038/s41598-017-00143-6.
Design of Allosteric Stimulators of the Hsp90 ATPase as New Anticancer Leads.
DAnnessa I, Sattin S, Tao J, Pennati M, Sanchez-Martin C, Moroni E
Chemistry. 2017; 23(22):5188-5192.
PMID: 28207175
PMC: 5927549.
DOI: 10.1002/chem.201700169.
